Previous close | 132.44 |
Open | 134.66 |
Bid | 135.79 x 200 |
Ask | 136.50 x 200 |
Day's range | 133.04 - 137.59 |
52-week range | 36.42 - 137.59 |
Volume | |
Avg. volume | 955,098 |
Market cap | 4.484B |
Beta (5Y monthly) | 1.87 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.34 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 119.20 |
Does TransMedics (TMDX) have what it takes to be a top stock pick for momentum investors? Let's find out.
On May 7, 2024, Edward Basile, Director at TransMedics Group Inc (NASDAQ:TMDX), sold 7,157 shares of the company.
Zacks.com users have recently been watching TransMedics (TMDX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.